Terms: = Skin cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
105 results:
1. Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.
Zhang Y; Zheng J; Chen M; Zhao S; Ma R; Chen W; Liu J
BMC Cancer; 2024 Apr; 24(1):519. PubMed ID: 38654216
[TBL] [Abstract] [Full Text] [Related]
2. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives.
Malekan M; Haass NK; Rokni GR; Gholizadeh N; Ebrahimzadeh MA; Kazeminejad A
Life Sci; 2024 May; 345():122563. PubMed ID: 38508233
[TBL] [Abstract] [Full Text] [Related]
3. The Transcriptional Landscape of Immune-Response 3'-UTR Alternative Polyadenylation in Melanoma.
Yang X; Wu Y; Chen X; Qiu J; Huang C
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474285
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract] [Full Text] [Related]
5. Circular RNA circFCHO2(hsa_circ_0002490) promotes the proliferation of melanoma by directly binding to DND1.
Yang Y; Li J; Wei C; Wang L; Gao Z; Shen K; Li Y; Ren M; Zhu Y; Ding Y; Wei C; Zhang T; Zheng S; Lu N; Gu J
Cell Biol Toxicol; 2024 Feb; 40(1):9. PubMed ID: 38311675
[TBL] [Abstract] [Full Text] [Related]
6. Paris polyphylla saponins II inhibits invasive, migration and epithelial-mesenchymal transition of melanoma cells through activation of autophagy.
Cheng H; Chu J; Yang Y; Li Y; Wang M; Wu H; Wang M; Su J; Li Q
Toxicon; 2024 Jan; 237():107558. PubMed ID: 38072315
[TBL] [Abstract] [Full Text] [Related]
7. The promoting effects of Grin2d expression in tumorigenesis and the aggressiveness of esophageal cancer.
Wang LL; Li J; Xue H; Zhang L; Yu DY; Yang N; Yun WJ; Zhao MZ; Xue H
Histol Histopathol; 2024 May; 39(5):659-670. PubMed ID: 37982578
[TBL] [Abstract] [Full Text] [Related]
8. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
9. miRNAs as potential game-changers in melanoma: A comprehensive review.
Abd-Allah GM; Ismail A; El-Mahdy HA; Elsakka EGE; El-Husseiny AA; Abdelmaksoud NM; Salman A; Elkhawaga SY; Doghish AS
Pathol Res Pract; 2023 Apr; 244():154424. PubMed ID: 36989843
[TBL] [Abstract] [Full Text] [Related]
10. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract] [Full Text] [Related]
11. Genetic testing in the evaluation of individuals with clinical diagnosis of atypical Sturge-Weber syndrome.
Yeom S; Cohen B; Weiss CR; Montano C; Wohler E; Sobreira N; Hammill AM; Comi A
Am J Med Genet A; 2023 Apr; 191(4):983-994. PubMed ID: 36710374
[TBL] [Abstract] [Full Text] [Related]
12. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract] [Full Text] [Related]
13. [Melanoma-associated macrophages-from molecular signals to therapeutic application].
Chatziioannou E; Aydin SA; Forchhammer S; Sinnberg T; Eigentler T
Dermatologie (Heidelb); 2022 Dec; 73(12):915-928. PubMed ID: 36394590
[TBL] [Abstract] [Full Text] [Related]
14. The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis.
Colasanti T; Stefanantoni K; Fantini C; Corinaldesi C; Vasile M; Marampon F; Di Luigi L; Antinozzi C; Sgrò P; Lenzi A; Riccieri V; Crescioli C
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077548
[TBL] [Abstract] [Full Text] [Related]
15. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
16. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
Shu W; Zhu X; Wang K; Cherepanoff S; Conway RM; Madigan MC; Zhu H; Zhu L; Murray M; Zhou F
Cell Oncol (Dordr); 2022 Aug; 45(4):601-619. PubMed ID: 35781872
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions.
Massimino M; Stella S; Micale G; Motta L; Pavone G; Broggi G; Piombino E; Magro G; Soto Parra HJ; Manzella L; Vigneri P
Cancer Genomics Proteomics; 2022; 19(3):350-361. PubMed ID: 35430568
[TBL] [Abstract] [Full Text] [Related]
18. Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling.
Park JJ; Stewart A; Irvine M; Pedersen B; Ming Z; Carlino MS; Diefenbach RJ; Rizos H
Cancer Gene Ther; 2022 Oct; 29(10):1384-1393. PubMed ID: 35352024
[TBL] [Abstract] [Full Text] [Related]
19. Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.
Chowers G; Abebe-Campino G; Golan H; Vivante A; Greenberger S; Soudack M; Barkai G; Fox-Fisher I; Li D; March M; Battig MR; Hakonarson H; Adams D; Dori Y; Dagan A
Pediatr Res; 2023 Dec; 94(6):1911-1915. PubMed ID: 35246606
[TBL] [Abstract] [Full Text] [Related]
20. New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma.
Wei AZ; Maniar AB; Carvajal RD
Cancer Gene Ther; 2022 Dec; 29(12):1819-1826. PubMed ID: 35236928
[TBL] [Abstract] [Full Text] [Related]
[Next]
